No Baby Blisters, available at 469-431-2343, announced its donation drive to provide life-saving support for babies with Epidermolysis Bullosa (EB) and their families.
-- No Baby Blisters, which describes itself as the only charity dedicated exclusively to supporting babies with Epidermolysis Bullosa (EB) and their families, announced a donation drive to provide direct medical assistance and emergency funding aimed at reducing suffering caused by the rare genetic skin disorder. Alongside financial support, the charity also works to raise awareness of EB, a condition that receives limited public attention and research funding despite its severe impact on affected children.
More details can be found at https://nobabyblisters.org/
Epidermolysis Bullosa is a rare genetic disorder that causes extremely fragile skin, often leading to blistering, open wounds, infections, and heightened cancer risk. Because of its rarity, institutional support and large-scale funding remain limited, leaving families to shoulder the relentless, around-the-clock demands of care with minimal outside assistance.
Founder Dr. Aaron Tabor, MD, said the charity was formed after identifying what he describes as a significant gap in care for children living with rare diseases. “To save the forgotten, medically neglected children, I founded No Baby Blisters,” Tabor said, referencing his research into rare pediatric conditions and the lack of structured support available to families in crisis.
The organization explains that donations are used to ensure that children do not run out of life-saving pain medication, clean bandages, antibiotics, blood transfusions, and emergency hospitalizations, with recurring monthly donors critical to maintaining uninterrupted access to these essential resources.
Beyond direct patient assistance, No Baby Blisters is advancing what it calls its Fast Cure Plan, a multimodal research initiative aimed at addressing EB at the systemic level. The approach includes gene therapy research designed to override mutated skin gene proteins, systemic treatment models intended to treat the entire body and not just isolated symptoms, and molecular research focused on reducing inflammation and supporting wound healing.
Tabor, an NIH-funded skin researcher and founder of GENIEXO, said long-term solutions require coordinated scientific effort. “As a rare disease, EB does not receive the same attention as more common conditions,” he noted, adding that the organization’s research partnerships include physicians, genetic therapy specialists, and regulatory experts.
The charity encourages individuals to participate in its recurring Hero Guardian Angel program, which provides tax-deductible monthly donations to support patient care and research efforts.
Those interested in learning more or becoming a donor can visit https://nobabyblisters.org/
Contact Info:
Name: Aaron Tabor
Email: Send Email
Organization: No Baby Blisters
Address: 731 Chapel Hills Drive , Colorado Springs, Colorado 80920, United States
Website: https://nobabyblisters.org/
Source: PressCable
Release ID: 89184535
Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.
